These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12972535)

  • 1. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
    Graziano F; Cascinu S
    J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab, bleeding, thrombosis, and warfarin.
    Kilickap S; Abali H; Celik I
    J Clin Oncol; 2003 Sep; 21(18):3542; author reply 3543. PubMed ID: 12972536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Future trends in anticancer chemotherapy].
    Kudoh S; Yamauchi S
    Nihon Rinsho; 2002 May; 60 Suppl 5():726-32. PubMed ID: 12101772
    [No Abstract]   [Full Text] [Related]  

  • 4. E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.
    Miller KD
    Clin Breast Cancer; 2003 Feb; 3(6):421-2. PubMed ID: 12636887
    [No Abstract]   [Full Text] [Related]  

  • 5. [Strategy of therapy for lung cancer].
    Kishi Y; Saijo N
    Nihon Rinsho; 2002 May; 60 Suppl 5():305-8. PubMed ID: 12101678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Paclitaxel].
    Hino M; Kudo S
    Nihon Rinsho; 2002 May; 60 Suppl 5():343-8. PubMed ID: 12101685
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenesis drug promising for metastatic colorectal cancer.
    McCarthy M
    Lancet; 2003 Jun; 361(9373):1959. PubMed ID: 12801743
    [No Abstract]   [Full Text] [Related]  

  • 8. Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Aug; 3(2):85-8. PubMed ID: 12952562
    [No Abstract]   [Full Text] [Related]  

  • 9. Antivascular endothelial growth factor monoclonal antibody therapy: a promising paradigm in colorectal cancer.
    Franson PJ; Lapka DV
    Clin J Oncol Nurs; 2005 Feb; 9(1):55-60. PubMed ID: 15751499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First- and second-line therapy of metastatic colorectal cancer.
    Terstriep S; Grothey A
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies.
    Geva R; Prenen H; Topal B; Aerts R; Vannoote J; Van Cutsem E
    J Surg Oncol; 2010 Dec; 102(8):937-45. PubMed ID: 21165996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM
    Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in diagnosis and treatment of lung cancer].
    Fukuoka M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():15-22. PubMed ID: 11989256
    [No Abstract]   [Full Text] [Related]  

  • 15. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
    Cercek A; Saltz LB
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
    Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
    Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS
    Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 20. Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.
    Windsor AC; Cohen R; Jiao LR; Stebbing J
    Future Oncol; 2008 Dec; 4(6):741-4. PubMed ID: 19086837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.